MNX1 and breast cancer: Moreover, when BC patients were categorized into subtypes, including luminal A, luminal B, HER2+, and TNBC subtypes, MNX1-AS1 expression was consistently higher in all subtypes of BC compared to corresponding normal tissue samples, with no statistically significant differences observed between the subtypes (Fig. S1B).